Highlights:
Significant Capital Injection
Thrive Tribe Technologies Limited (ASX:1TT), a prominent player in innovative technology solutions, has successfully raised $1,000,000 through a funding initiative targeted at sophisticated and professional investors. At the time of writing, this substantial capital raise underscores the company's commitment to strengthening its financial base and accelerating its strategic goals.
Details of the Capital Raise
The funding will be achieved by issuing 625,000,000 new shares at $0.0016 per share, reflecting a 20% discount to the five-day Volume Weighted Average Price (VWAP). This discounted pricing strategy aims to attract investors while maintaining shareholder value. The capital will primarily be allocated for working capital, ensuring Thrive Tribe's operational and growth objectives are well-funded.
Clee Capital’s Role as Lead Manager
Clee Capital Pty Ltd has been appointed as the lead manager for this placement. For their role, Clee Capital will receive 6% of the total funds raised, excluding GST. This partnership reflects Thrive Tribe’s strategy to engage experienced financial managers to streamline the capital-raising process and maximize investment efficiency.
Shareholder Approval
The new shares will be issued in accordance with resolution 4, approved by shareholders during the Annual General Meeting held on November 22, 2024. This approval highlights the alignment between Thrive Tribe's management and its shareholders in pursuing the company’s growth strategy.
Future Outlook
This capital injection positions Thrive Tribe Technologies Limited to reinforce its financial foundation and sustain its business trajectory. The company's board has expressed confidence in leveraging this funding to enhance operational stability and long-term shareholder value.
This milestone demonstrates Thrive Tribe’s ability to attract investor confidence while focusing on sustainable growth.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Jan 17, 2025
Jan 17, 2025
Jan 17, 2025
Jan 16, 2025
Jan 16, 2025
Jan 15, 2025
Jan 15, 2025
Jan 15, 2025
Jan 14, 2025
Jan 14, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.